PI
IONS icon

Putnam Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Putnam Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-20,570
Closed -$833K – 1370
2016
Q1 		$833K Buy
20,570
+417
+2% +$16.9K ﹤0.01% 1149
2015
Q4 		$1.25M Sell
20,153
-376
-2% -$20.3K ﹤0.01% 1105
2015
Q3 		$830K Buy
+20,529
New +$1.06M ﹤0.01% 1215
2015
Q2 		– Sell
-53,890
Closed -$3.43M – 1514
2015
Q1 		$3.43M Sell
53,890
-1,936
-3% -$131K 0.01% 894
2014
Q4 		$3.45M Sell
55,826
-315
-0.6% -$15.5K 0.01% 878
2014
Q3 		$2.18M Buy
56,141
+26,837
+92% +$951K ﹤0.01% 1002
2014
Q2 		$1.01M Buy
29,304
+55
+0.2% +$1.73K ﹤0.01% 1189
2014
Q1 		$1.26M Sell
29,249
-1,899
-6% -$92.1K ﹤0.01% 1154
2013
Q4 		$1.24M Sell
31,148
-478
-2% -$17K ﹤0.01% 1158
2013
Q3 		$1.19M Buy
31,626
+10,131
+47% +$303K ﹤0.01% 1183
2013
Q2 		$577K Buy
+21,495
New +$457K ﹤0.01% 1302

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Putnam Investments's IONS Position: Q2 2016 in Review

Putnam Investments sold out of Ionis Pharmaceuticals (IONS) in Q2 2016, closing a stake of 20,570 shares — an estimated $833K sold.

Putnam Investments first reported a position in IONS in Q2 2013 and held it in 11 quarters. The position peaked at $3.45M in Q4 2014. 282 funds tracked by Wall St. Rank hold IONS as of Q2 2016.

  • Putnam Investments reported no remaining Ionis Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Putnam Investments sold 20,570 Ionis Pharmaceuticals shares in Q2 2016, an estimated $833K.
  • Putnam Investments first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Putnam Investments's Ionis Pharmaceuticals position peaked at $3.45M in Q4 2014.
  • 282 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2016.

Based on Putnam Investments's 13F filing for Q2 2016, filed 15 Aug 2016.